Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M; MINDACT Investigators. Cardoso F, et al. Among authors: neijenhuis pa. N Engl J Med. 2016 Aug 25;375(8):717-29. doi: 10.1056/NEJMoa1602253. N Engl J Med. 2016. PMID: 27557300 Free article. Clinical Trial.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Piccart M, van 't Veer LJ, Poncet C, Lopes Cardozo JMN, Delaloge S, Pierga JY, Vuylsteke P, Brain E, Vrijaldenhoven S, Neijenhuis PA, Causeret S, Smilde TJ, Viale G, Glas AM, Delorenzi M, Sotiriou C, Rubio IT, Kümmel S, Zoppoli G, Thompson AM, Matos E, Zaman K, Hilbers F, Fumagalli D, Ravdin P, Knox S, Tryfonidis K, Peric A, Meulemans B, Bogaerts J, Cardoso F, Rutgers EJT. Piccart M, et al. Among authors: neijenhuis pa. Lancet Oncol. 2021 Apr;22(4):476-488. doi: 10.1016/S1470-2045(21)00007-3. Epub 2021 Mar 12. Lancet Oncol. 2021. PMID: 33721561 Clinical Trial.
[Breast-specific gamma imaging in breast cancer].
van Loevezijn AA, van Breda Vriesman AC, Neijenhuis PA, Pereira Arias-Bouda LM. van Loevezijn AA, et al. Among authors: neijenhuis pa. Ned Tijdschr Geneeskd. 2016;160:A9610. Ned Tijdschr Geneeskd. 2016. PMID: 26786798 Dutch.
Evolutions in rectal cancer MRI staging and risk stratification in The Netherlands.
Bogveradze N, El Khababi N, Schurink NW, van Griethuysen JJM, de Bie S, Bosma G, Cappendijk VC, Geenen RWF, Neijenhuis P, Peterson G, Veeken CJ, Vliegen RFA, Maas M, Lahaye MJ, Beets GL, Beets-Tan RGH, Lambregts DMJ. Bogveradze N, et al. Abdom Radiol (NY). 2022 Jan;47(1):38-47. doi: 10.1007/s00261-021-03281-8. Epub 2021 Oct 4. Abdom Radiol (NY). 2022. PMID: 34605966 Free PMC article.
The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.
Collarino A, Valdés Olmos RA, van Berkel LGAJ, Neijenhuis PA, Wijers LMH, Smit F, de Geus-Oei LF, Pereira Arias-Bouda LM. Collarino A, et al. Among authors: neijenhuis pa. Breast Cancer Res Treat. 2018 Jun;169(3):513-522. doi: 10.1007/s10549-018-4706-1. Epub 2018 Feb 13. Breast Cancer Res Treat. 2018. PMID: 29435855 Free PMC article.
Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT).
Brouwer OR, Vermeeren L, van der Ploeg IM, Valdés Olmos RA, Loo CE, Pereira-Bouda LM, Smit F, Neijenhuis P, Vrouenraets BC, Sivro-Prndelj F, Jap-a-Joe SM, Borgstein PJ, Rutgers EJ, Oldenburg HS. Brouwer OR, et al. Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1137-43. doi: 10.1007/s00259-012-2131-y. Epub 2012 Apr 24. Eur J Nucl Med Mol Imaging. 2012. PMID: 22526968 Clinical Trial.
75 results